symbols : NVO save search
Novo Nordisk A/S – Share repurchase programme
Published: 2022-01-17 (Crawled : 23:00) - globenewswire.com
NVO | $95.46 |
|
Health Technology
Novo Nordisk Brokers Another Deal in Fight Against Obesity
Published: 2022-01-17 (Crawled : 16:00) - biospace.com/
NVO | $95.46 |
|
Health Technology
obesity deal
Novo Nordisk announces settlement of securities lawsuit in Denmark
Published: 2022-01-14 (Crawled : 17:00) - globenewswire.com
NVO | $95.46 |
|
Health Technology
|
| O: -3.67%
H: 0.0%
C: 0.0%
ces
Human Growth Hormone (hGH) Market to Reach $9.21 Billion, By 2030 at 9.0% CAGR: AMR
Published: 2022-01-14 (Crawled : 01:00) - prnewswire.com
VTRS | $14.64 |
|
Health Technology
|
| O: -1.64%
H: 0.0%
C: 0.0%
NVO | $95.46 |
|
Health Technology
|
| O: -3.67%
H: 0.0%
C: 0.0%
LLY | News | $246.46 |
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
ABT | News | $126.36 |
|
Health Technology
|
| O: -1.54%
H: 0.0%
C: 0.0%
growth hormone growth hormone
Novo Nordisk A/S – Share repurchase programme
Published: 2022-01-10 (Crawled : 13:30) - globenewswire.com
NVO | $95.46 |
|
Health Technology
|
| O: -0.41%
H: 1.79%
C: 1.66%
2seventy bio Announces Expanded Collaboration Agreement With Novo Nordisk to Continue Development of in vivo Gene Editing Approach
Published: 2022-01-06 (Crawled : 12:30) - biospace.com/
TSVT | $19.84 |
|
|
| O: 5.11%
H: 6.69%
C: 4.86%
NVO | $95.46 |
|
Health Technology
|
| O: -3.91%
H: 3.22%
C: 2.12%
ces collaboration
Innate Pharma Obtains €28.7m in Non-Dilutive Financing in the Form of State Guaranteed Loans
Published: 2022-01-05 (Crawled : 12:00) - biospace.com/
NVO | $95.46 |
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
SNY | News 3 d | $52.31 |
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
BNPQF | News | $72.36 |
|
Finance
|
| O: 2.94%
H: 0.0%
C: -3.23%
SNYNF | News 3 d | $105.0 |
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
IPHA | $4.43 |
|
Health Technology
|
| O: 3.0%
H: 1.25%
C: -0.42%
BNPQY | News | $35.98 |
|
Finance and Insurance
|
| O: 1.62%
H: 0.17%
C: -1.98%
Novo Holdings to acquire Ritedose
Published: 2022-01-04 (Crawled : 11:00) - prnewswire.com
NVO | $95.46 |
|
Health Technology
|
| O: -5.25%
H: 0.0%
C: 0.0%
Innate Pharma to Participate in Upcoming Investor Conferences - Jan 04, 2022
Published: 2022-01-04 (Crawled : 10:00) - biospace.com/
IPHA | $4.43 |
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: -2.51%
NVO | $95.46 |
|
Health Technology
|
| O: -5.25%
H: 0.0%
C: 0.0%
SNY | News 3 d | $52.31 |
|
Health Technology
|
| O: -2.03%
H: 0.0%
C: 0.0%
ces conference
Novo Holdings participates in EUR 110 million first closing of Sound Bioventures Fund I
Published: 2022-01-04 (Crawled : 07:00) - prnewswire.com
NVO | $95.46 |
|
Health Technology
|
| O: -5.25%
H: 0.0%
C: 0.0%
At 9.7% CAGR, Insulin Delivery Devices Market Size to hit USD 33.05 Billion in 2028, Says Brandessence Market Research
Published: 2022-01-03 (Crawled : 12:00) - prnewswire.com
LLY | News | $246.46 |
|
Health Technology
|
| O: -0.78%
H: 0.0%
C: 0.0%
PODD | $232.32 |
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
MDT | News | $106.11 |
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
BDX | $263.97 |
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
NVO | $95.46 |
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
ces ce mark device research liver insulin
Novo Nordisk A/S – Share repurchase programme
Published: 2021-12-22 (Crawled : 15:30) - globenewswire.com
NVO | $95.46 |
|
Health Technology
|
| O: 2.31%
H: 1.39%
C: 1.14%
Novo Holdings invests EUR 86 million in 21st.BIO, a new bioindustrial scale-up company building on technology base from Novozymes
Published: 2021-12-21 (Crawled : 07:00) - prnewswire.com
NVO | $95.46 |
|
Health Technology
|
| O: 1.2%
H: 1.62%
C: 1.37%
technology trial
Global $19 Billion Home-Use Insulin Delivery Devices Markets, 2015-2020 & 2021-2030
Published: 2021-12-20 (Crawled : 19:00) - prnewswire.com
NVO | $95.46 |
|
Health Technology
|
| O: 1.2%
H: 1.62%
C: 1.37%
MDT | News | $106.11 |
|
Health Technology
|
| O: 0.45%
H: 2.78%
C: 1.68%
BDX | $263.97 |
|
Health Technology
|
| O: 0.57%
H: 0.63%
C: -0.8%
SNY | News 3 d | $52.31 |
|
Health Technology
|
| O: 0.76%
H: 0.67%
C: 0.45%
LLY | News | $246.46 |
|
Health Technology
|
| O: 0.2%
H: 0.74%
C: 0.33%
PODD | $232.32 |
|
Health Technology
|
| O: 0.29%
H: 3.22%
C: 3.08%
ces device liver insulin
Novo Nordisk announces supply challenges for Wegovy® in the US
Published: 2021-12-17 (Crawled : 19:00) - globenewswire.com
NVO | $95.46 |
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
wegovy ces
Innate Pharma: First Patient Dosed in IPH6101/SAR443579 Phase 1/2 Clinical Trial in Various Blood Cancers
Published: 2021-12-16 (Crawled : 09:00) - biospace.com/
NVO | $95.46 |
|
Health Technology
|
| O: 2.6%
H: 0.0%
C: 0.0%
SNY | News 3 d | $52.31 |
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
SNYNF | News 3 d | $105.0 |
|
Health Technology
|
| O: -5.02%
H: 5.6%
C: 0.96%
IPHA | $4.43 |
|
Health Technology
|
| O: -1.27%
H: 1.68%
C: 0.5%
IPHYF | $4.915 |
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
iph6101 blood trial phase 1 cancer
Transdermal Drug Delivery Market is Growing at a CAGR of 9.8% during the Study Period from 2021 to 2026, Asserts DelveInsight
Published: 2021-12-14 (Crawled : 17:00) - prnewswire.com
TRUMF | $37.594 |
|
Health Technology
|
| O: -1.42%
H: 0.02%
C: 0.02%
MDT | News | $106.11 |
|
Health Technology
|
| O: -0.2%
H: 0.66%
C: -0.52%
BDX | $263.97 |
|
Health Technology
|
| O: -0.3%
H: 0.1%
C: -1.63%
SNY | News 3 d | $52.31 |
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
AZN | News | $60.17 |
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
ATRS | $3.35 |
|
Health Technology
|
| O: -0.31%
H: 0.7%
C: -0.63%
TRUMY | $36.85 |
|
Manufacturing
|
| O: -1.37%
H: 0.68%
C: 0.37%
NVO | $95.46 |
|
Health Technology
|
| O: -1.8%
H: 0.08%
C: -0.43%
AZNCF | News | $121.21 |
|
Health Technology
|
| O: -1.44%
H: 5.82%
C: 1.91%
LLY | News | $246.46 |
|
Health Technology
|
| O: 0.82%
H: 0.92%
C: 0.66%
PODD | $232.32 |
|
Health Technology
|
| O: -0.82%
H: 0.38%
C: -2.71%
ENDP | $3.32 |
|
Health Technology
|
| O: -5.76%
H: 7.53%
C: 0.47%
SNYNF | News 3 d | $105.0 |
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
JNJ | News | $167.27 |
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: 0.0%
BMY | $64.58 |
|
Health Technology
|
| O: 2.71%
H: 2.77%
C: 1.21%
drug liver growing drug delivery
Novo Nordisk A/S – Share repurchase programme
Published: 2021-12-13 (Crawled : 21:00) - globenewswire.com
NVO | $95.46 |
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress
Published: 2021-12-09 (Crawled : 11:00) - biospace.com/
NVO | $95.46 |
|
Health Technology
|
| O: 1.09%
H: 0.32%
C: -0.26%
SNY | News 3 d | $52.31 |
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
IPHA | $4.43 |
|
Health Technology
|
| O: 0.2%
H: 1.6%
C: -2.8%
cancer
Needle-Free Injections Market is Growing at a CAGR of 14.15% during the Forecast Period from 2021 to 2026 and will reach USD 24.12 billion by 2026, Affirms DelveInsight
Published: 2021-12-06 (Crawled : 17:00) - prnewswire.com
TRUMF | $37.594 |
|
Health Technology
|
| O: 0.5%
H: 0.19%
C: -2.25%
TRUMY | $36.85 |
|
Manufacturing
|
| O: 0.12%
H: 0.2%
C: 0.12%
NVO | $95.46 |
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: 0.0%
WST | $373.59 |
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
LLY | News | $246.46 |
|
Health Technology
|
| O: -2.2%
H: 0.0%
C: 0.0%
ABBV | News | $134.37 |
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
JNJ | News | $167.27 |
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: 0.0%
injection growing
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
COTY | News | $8.64 |
|
Consumer Non-Durables
DXR | News | $11.16 |
|
Health Technology
FCFS | News | $73.31 |
|
Finance
INCY | News | $74.76 |
|
Health Technology
KRP | News | $14.73 |
|
Miscellaneous
LLY | News | $246.46 |
|
Health Technology
OVLY | News | $17.6 |
|
Finance